Related Experiment Video
Updated: Jan 21, 2026

Spatial Molecular Imaging of the Glycome Using Mass Spectrometry
Published on: November 28, 2025
Defining Protein Pattern Differences Among Molecular Subtypes of Diffuse Gliomas Using Mass Spectrometry
Ugljesa Djuric1, K H Brian Lam2, Jennifer Kao2
1Princess Margaret Cancer Centre, MacFeeters Hamilton Centre for Neuro-Oncology Research, College Street 101, Toronto, Ontario, M5G 1L7, Canada; Laboratory Medicine Program, University Health Network, 200 Elizabeth Street, Toronto, ON, Toronto, Ontario, M5G 2C4, Canada.
This study reveals distinct protein profiles in diffuse gliomas based on IDH and 1p19q codeletion status. Proteomics identified key proteins in invasiveness and mRNA splicing, offering potential therapeutic targets for these aggressive brain tumors.
Area of Science:
- Proteomics and molecular oncology
- Cancer biology and systems biology
Background:
- Diffuse gliomas are lethal brain malignancies with limited molecular characterization beyond genomics and transcriptomics.
- Understanding protein-level alterations is crucial for deciphering glioma biology and identifying therapeutic targets.
Purpose of the Study:
- To characterize diffuse gliomas at the proteome level by integrating mass spectrometry data with genomic classifications.
- To identify protein abundance differences associated with IDH mutation and 1p19q codeletion status in glioma subtypes.
- To compare proteomic findings in primary tissues with glioblastoma stem-like cells (GSCs) to identify potential drivers.
Main Methods:
- Mass spectrometry was used to quantify 5,496 proteins in bulk and macrodissected tissues from three distinct glioma cohorts (IDH wild type, IDH mutated/1p19q non-codeleted, IDH mutated/1p19q-codeleted).
- Proteomic data were analyzed using clustering to identify systems-level pathway differences.
- Abundance changes were compared between primary tissues and IDH-matched GSCs.
Main Results:
- Proteomic clustering revealed significant differences in pathways based on IDH and 1p19q codeletion status.
- IDH wild-type gliomas showed enrichment of proteins associated with invasiveness and epithelial-to-mesenchymal transition (EMT).
- IDH mutated gliomas exhibited increased protein abundance related to mRNA splicing.
- Specific proteins involved in chloride transport (CLIC1) and EMT (PLOD3, SERPINH1) demonstrated concordant IDH-status-dependent abundance changes in both primary tissues and GSCs.
Conclusions:
- Proteomic profiling provides critical insights into the molecular heterogeneity of diffuse gliomas, complementing genomic and transcriptomic data.
- Distinct proteomic signatures correlate with IDH and 1p19q codeletion status, highlighting subtype-specific biological processes.
- Identification of proteins involved in invasiveness, EMT, and mRNA splicing offers potential avenues for developing targeted therapies for aggressive gliomas.
Related Concept Videos
Mass Spectrometry: Molecular Fragmentation Overview
One type of fragmentation pattern is the cleavage of a single bond in the molecular ion. The cleavage leads to a radical and a cation. The cleavage can occur at...
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Polymers: Defining Molecular Weight
The number average molecular weight (Mn) is the summation of the number...
Tandem Mass Spectrometry
Mass Spectrometry: Overview
Mass Spectrometry of Amines

